T-cell receptor beta variable 2 (TRBV2) (TRBV2)

T-cell receptor beta variable 2 (TRBV2) is a specific variable segment of the T-cell receptor (TCR) beta chain, playing a fundamental role in the adaptive immune system's ability to recognize diverse antigens (HGNC:12214). As a component of the TCR complex, it facilitates the recognition of peptides presented by the Major Histocompatibility Complex (MHC) on antigen-presenting cells (UniProt:P04213). TRBV2 is of significant clinical interest because it serves as the primary binding site for the bacterial superantigen Toxic Shock Syndrome Toxin-1 (TSST-1), which triggers massive, polyclonal T-cell activation and systemic inflammation (PubMed:10438934). This specific interaction makes TRBV2 a key player in the pathogenesis of Toxic Shock Syndrome and has been implicated in the etiology of Kawasaki disease (PubMed:21169520). In the realm of drug development, TRBV2 is targeted by experimental monoclonal antibodies and small molecules designed to neutralize superantigen effects or to selectively modulate T-cell populations in autoimmune diseases. Monitoring the expansion of TRBV2-expressing T-cells serves as a vital biomarker for diagnosing superantigen-mediated illnesses and assessing the efficacy of immunomodulatory treatments. Furthermore, the structural characterization of TRBV2 is essential for the development of TCR-engineered therapies that aim to harness or suppress specific T-cell responses.

Other names

TCRBV2Vb2T-cell receptor beta variable 2-1TRBV2-1T-cell receptor beta chain variable region Vbeta2

Binding to the V-beta region of the T-cell receptor to induce polyclonal T-cell activation or neutralization of such binding to prevent cytokine storms.